1. Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM: Definition and antagonism of histamine H2 receptors. Nature 236:385, 1972
2. Takeda M, Takage T, Maeno H: Effect of a new potent H2 blocker, 3-({[2-diaminomethylene)amino]-4-thiazolyl}methyl)thio-N 2-sulfamoylpropionamidine (YM-11170), on gastric secretion, ulcer formation, and weight of male accessory sex organs in rats. Arzneim Forsch 32:734?737, 1982
3. Takage T, Takeda M, Maeno H: Effect of a new potent H2 blocker, 3-({[2-diaminomethylene)amino]-4-thiazolyl}methyl)thio-N 2-sulfamoylpropionamidine (YM-11170), on gastric secretion induced by histamine and food in conscious dogs. Arch Int Pharmacodyn Ther 256:49?58, 1982
4. Pendleton RG, Torchiana ML, Chung C, Cook P, Wiese S, Clineschmidt BV: Studies on MK-208 (YM-11170) a new slowly dissociable H2-receptor antagonist. Arch Int Pharmacodyn Ther 266:4?16, 1983
5. Smith JL, Chremos AN, Gamal M, Graham DY: Gastric antisecretory effects in man of a novel H2-receptor inhibitor 3-({[2-diaminomethylene)amino]-4-thiazolyl}methyl)thio-N 2-sulfamoylpropionamidine (MK-208). Clin Pharm Ther 33:216, 1983